Evidence for direct CFTR inhibition by CFTR(inh)-172 based on Arg347 mutagenesis

Biochem J. 2008 Jul 1;413(1):135-42. doi: 10.1042/BJ20080029.

Abstract

CFTR (cystic fibrosis transmembrane conductance regulator) is an epithelial Cl- channel inhibited with high affinity and selectivity by the thiazolidinone compound CFTR(inh)-172. In the present study, we provide evidence that CFTR(inh)-172 acts directly on the CFTR. We introduced mutations in amino acid residues of the sixth transmembrane helix of the CFTR protein, a domain that has an important role in the formation of the channel pore. Basic and hydrophilic amino acids at positions 334-352 were replaced with alanine residues and the sensitivity to CFTR(inh)-172 was assessed using functional assays. We found that an arginine-to-alanine change at position 347 reduced the inhibitory potency of CFTR(inh)-172 by 20-30-fold. Mutagenesis of Arg347 to other amino acids also decreased the inhibitory potency, with aspartate producing near total loss of CFTR(inh)-172 activity. The results of the present study provide evidence that CFTR(inh)-172 interacts directly with CFTR, and that Arg347 is important for the interaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Animals
  • Arginine
  • Benzoates / chemistry
  • Benzoates / pharmacology*
  • Cell Line
  • Cystic Fibrosis Transmembrane Conductance Regulator / antagonists & inhibitors*
  • Humans
  • Ion Channel Gating / drug effects
  • Ion Channel Gating / physiology
  • Molecular Structure
  • Mutagenesis
  • Protein Binding
  • Rats
  • Thiazolidines / chemistry
  • Thiazolidines / pharmacology*

Substances

  • 3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone
  • Benzoates
  • Thiazolidines
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Arginine